Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (739)	5/5/1998 11:28:00 PM
From: Graham Dellaire	Read Replies (1) \| Respond to of 2135

I am with ya mudd! Sold at 70 in at 10.5. THis is a great story stock with the real deal. But way way too far ahead of itself. If you want to see a similar potential in a biotech. Look at a small company by the name of Micrologix (TSE:MBI). These guys have the next generation antibiotic. Their drugs work to enhance the activity of current antibiotics (ease of prescription by your Doc!) and have also a set of bacteriolysins that kill VRE and some other nasty antibiotic resistant bugs. They have a thread on SI and they are at a nice price (3 bucks Canadian). They will have and IND this fall for a topical antibiotic. Should be up at 5-6 bucks within 6 months and if they sign with a major pharma 20 o 30 bucks a share could be your target! Cheers, Graham